创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Progress in Neuropharmacology
WU Qimei, GE Jian
2019, 43(2): 83-92.
Abstract PDF
Advances in the Role of Tet Protein in the Progression of Alzheimer's Disease
ZHANG Hong, LIU Haochen, HE Hua, LIU Xiaoquan
2019, 43(2): 93-99.
Abstract PDF
Progress in Drug Development for Alzheimer's Disease
ZHENG Yilin, XIE Qiong, XIAO Li, LI Qiu, XU Lili, SHAO Liming
2019, 43(2): 100-110.
Abstract PDF
Research Advance in NGF in Neuropathic Pain and Related Drugs
YAN Bing, DAI Wenling, LIU Jihua
2019, 43(2): 111-117.
Abstract PDF
Recent Advances in Inhibitors of Histone Acetyltransferase p300/CBP
WU Jun, WANG Yazhou, YANG Shengwei, LI Zhiyu
2019, 43(2): 118-126.
Abstract PDF
Research Progress in tRNA-associated Dysregulation in Type 2 Diabetes Mellitus
ZHANG Xiaochuan, SUN Bao, ZHOU Zheng, LI Xiaoping
2019, 43(2): 127-132.
Abstract PDF
Analysis and Countermeasure of Consistency Evaluation Work for Generic Drugs in Changzhou
PAN Huayang, GUO Wei, TENG Yiwan, XIE Shujiang, JIANG Pengju
2019, 43(2): 133-140.
Abstract PDF
Reviews of FDA New Drug Approvals in 2018 (Ⅱ)
WEI Lijun
2019, 43(2): 141-157.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in January 2019
SUN Yousong
2019, 43(2): 158-160.
Abstract PDF